Efficacy and Safety of High Doses of Safinamide in Advanced Parkinson's Disease Patients in a Real-World Experience

被引：0
|
作者：
Rodriguez Jorge, F. [1 ]
Beltran Corbellini, A. [1 ]
Parra Diaz, P. [1 ]
Chico Garcia, J. L. [1 ]
Pagonabarraga Mora, J. [1 ]
Baena Alvarez, B. [1 ]
Parees Moreno, I. [1 ]
Lopez-Sendon, J. L. [1 ]
Perez Torre, P. [1 ]
Martinez Castrillo, J. C. [1 ]
Alonso Canovas, A. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Madrid, Spain
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1053
引用
收藏
页码：S477 / S477
页数：1
相关论文
共 50 条
  • [21] Real-World Utilization of Istradefylline Among Patients with Parkinson's Disease
    Rezak, M.
    Qian, J.
    Zhao, Y.
    Silverstein, A.
    Chamber, J.
    Swindle, J.
    Kronfeld, N.
    LeWitt, P.
    MOVEMENT DISORDERS, 2023, 38 : S622 - S622
  • [22] Real-world characteristics of advanced Parkinson's disease patients initiating carbidopa/levodopa enteral suspension
    Soileau, M.
    Malaty, I.
    Aldred, J.
    Merola, A.
    Rodriguez, R.
    Gupta, N.
    Sultan, I.
    Kandukuri, P.
    Jalundhwala, Y.
    Ladhani, O.
    Pan, I.
    Pahwa, R.
    MOVEMENT DISORDERS, 2021, 36 : S235 - S236
  • [23] Effectiveness of Opicapone in Parkinson's according to baseline use of safinamide: the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 321 - 321
  • [24] Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience
    Masarone, Daniele
    Valente, Fabio
    Verrengia, Marina
    Ammendola, Ernesto
    Gravino, Rita
    D'Alterio, Giuliano
    Petraio, Andrea
    Pacileo, Giuseppe
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (11) : 919 - 921
  • [25] Real-world experience with ocrelizumab - a safety and efficacy clinical analysis
    Bolling, J.
    Rempe, T.
    Vasquez, M.
    Sollero, C. Vervloet
    Carlson, A.
    Gyang, T.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 550 - 550
  • [26] Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson's disease
    Kurihara, Kanako
    Mishima, Takayasu
    Fujioka, Shinsuke
    Tsuboi, Yoshio
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (02) : 137 - 147
  • [27] The safety and efficacy of palbociclib in older patients with advanced breast cancer in a real-world setting
    Gouton, Etienne
    Tassy, Louis
    Micallef, Joelle
    Meskine, Amir
    Sabatier, Renaud
    Cecile-Herry, Maud
    Braticevic, Cecile
    Goncalves, Anthony
    Viret, Frederic
    de Nonneville, Alexandre
    Montegut, Coline
    Rouby, Franck
    Rousseau, Frederique
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2022, 8
  • [28] Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
    Lee, Seunghwan
    Park, Se Jun
    Shin, Kabsoo
    Hong, Tae Ho
    Kim, In-Ho
    Lee, Myung Ah
    BMC CANCER, 2024, 24 (01)
  • [29] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: Findings from the real-world OPTIPARK study
    Pavese, Nicola
    Lees, Andrew
    Reichmann, Heinz
    Martins, Diogo
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 268 - 269
  • [30] Effectiveness of opicapone in Parkinson's disease patients with motor fluctuations according to baseline use of safinamide: findings from the real-world OPTIPARK study
    Pavese, N.
    Lees, A.
    Reichmann, H.
    Martins, D.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2021, 36 : S228 - S229
12345